1541 — ImmuneOnco Biopharmaceuticals Shanghai Cashflow Statement
0.000.00%
Last trade - 00:00- HK$5.17bn
- HK$5.25bn
- CNY0.39m
Annual cashflow statement for ImmuneOnco Biopharmaceuticals Shanghai, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | ARS |
| Standards: | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final |
| Net Income/Starting Line | -733 | -403 | -379 |
| Depreciation | |||
| Non-Cash Items | 555 | 134 | 75.4 |
| Unusual Items | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | -25.7 | 12.5 | -86.1 |
| Change in Accounts Receivable | |||
| Change in Prepaid Expenses | |||
| Change in Accounts Payable | |||
| Other Operating Cash Flow | |||
| Cash from Operating Activities | -191 | -239 | -368 |
| Capital Expenditures | -125 | -23.2 | -2.69 |
| Purchase of Fixed Assets | |||
| Other Investing Cash Flow Items | 16.5 | 23.3 | -292 |
| Sale of Fixed Assets | |||
| Sale/Maturity of Investment | |||
| Purchase of Investments | |||
| Other Investing Cash Flow | |||
| Cash from Investing Activities | -109 | 0.049 | -295 |
| Financing Cash Flow Items | -3.17 | -4.39 | -30.5 |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | 793 | 179 | 331 |
| Foreign Exchange Effects | |||
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | 485 | -33.1 | -328 |